Royce & Associates LP Insulet Corp Transaction History

Royce & Associates LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$161.02 - $206.98 $2.55 Million - $3.28 Million	15,863 Added 800.76%	17,844 $3.6 Million
Q1 2024 May 13, 2024	SELL	$163.6 - $209.11 $6.02 Million - $7.7 Million	-36,813 Reduced 94.89%	1,981 $339,000
Q4 2023 Feb 12, 2024	BUY	$127.77 - $221.42 $4.96 Million - $8.59 Million	38,794 New	38,794 $8.42 Million

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.3B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.